Results 261 to 270 of about 1,013,822 (289)
Some of the next articles are maybe not open access.
Current Opinion in Hematology, 2013
In the past 20 years, several pathogen inactivation technologies have been developed to be applied to blood components. This review is intended to summarize the data currently available about the technologies and the clinical use of products inactivated by those techniques.Technologies for inactivating pathogens in plasma and platelets are available ...
Miguel, Lozano, Joan, Cid
openaire +2 more sources
In the past 20 years, several pathogen inactivation technologies have been developed to be applied to blood components. This review is intended to summarize the data currently available about the technologies and the clinical use of products inactivated by those techniques.Technologies for inactivating pathogens in plasma and platelets are available ...
Miguel, Lozano, Joan, Cid
openaire +2 more sources
Inactivation of poliovirus by formaldehyde. Analysis of inactivation curves
Archiv f�r die gesamte Virusforschung, 1957As previously reported the equation logy 0 − logy=ta log (1+b t) has been found to describe the course of inactivation of poliovirus by formaldehyde. The present paper reports and discusses different methods of fitting this equation to experimental data. With the aid of the methods described data recently published byHaas et al. and byTimm et al.
S, GARD, E, LYCKE
openaire +2 more sources
1983
I’d like to discuss some of our efforts towards the design of highly specific enzyme inactivators, which can be used in vivo. We hope that such inactivators can be useful as pharmacological agents.
openaire +2 more sources
I’d like to discuss some of our efforts towards the design of highly specific enzyme inactivators, which can be used in vivo. We hope that such inactivators can be useful as pharmacological agents.
openaire +2 more sources
Current Opinion in Hematology, 2015
To review data about transfusion-transmitted infections so as to assess potential safety benefits of applying pathogen inactivation technology to platelets.Residual bacterial risk still exists. Multiple arbovirus epidemics continue to occur and challenge blood safety policy makers in nonendemic developed countries.
openaire +2 more sources
To review data about transfusion-transmitted infections so as to assess potential safety benefits of applying pathogen inactivation technology to platelets.Residual bacterial risk still exists. Multiple arbovirus epidemics continue to occur and challenge blood safety policy makers in nonendemic developed countries.
openaire +2 more sources
THE INACTIVATION OF TRYPSIN : III. SPONTANEOUS INACTIVATION.
The Journal of general physiology, 20101. The rate of inactivation of purified trypsin solutions approximates closely that demanded by the monomolecular formula. The more carefully the solution is purified the closer the agreement with the formula. 2. The products formed by the action of trypsin on proteins renders the trypsin more stable. Gelatin and glycine have no effect. 3.
openaire +1 more source